Drugs / FS Grifols
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00684047 | Feb 2008 → Mar 2014 | bleeding disorder, vascular-type | Grifols, S.A. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FS Grifols | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00684047 ↗ |
| Known as | Fibrin Sealant Grifols | “Fibrin Sealant Grifols (FS Grifols). Preliminary Part (I)” NCT00684047 ↗ |
| Modality | Protein / enzyme biologic | “human plasma-derived fibrin sealant Grifols (FS Grifols)” NCT00684047 ↗ |